ID   OPCM_HUMAN              Reviewed;         345 AA.
AC   Q14982; B2CZX2; B7ZLQ1; Q17RN7; Q7Z3W6;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   07-APR-2021, entry version 183.
DE   RecName: Full=Opioid-binding protein/cell adhesion molecule;
DE            Short=OBCAM;
DE            Short=OPCML;
DE            Short=Opioid-binding cell adhesion molecule;
DE   AltName: Full=IgLON family member 1;
DE   Flags: Precursor;
GN   Name=OPCML; Synonyms=IGLON1, OBCAM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Occipital cortex;
RX   PubMed=7721093; DOI=10.1016/0378-1119(94)00830-l;
RA   Shark K.B., Lee N.M.;
RT   "Cloning, sequencing and localization to chromosome 11 of a cDNA encoding a
RT   human opioid-binding cell adhesion molecule (OBCAM).";
RL   Gene 155:213-217(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3).
RA   Cui Y., Tao Q.;
RT   "Multiple promoters and alternative splicing of OPCML.";
RL   Submitted (APR-2008) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Brain, and Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RC   TISSUE=Brain, and Fetal brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   VARIANT OVARIAN CANCER ARG-95.
RX   PubMed=12819783; DOI=10.1038/ng1183;
RA   Sellar G.C., Watt K.P., Rabiasz G.J., Stronach E.A., Li L., Miller E.P.,
RA   Massie C.E., Miller J., Contreras-Moreira B., Scott D., Brown I.,
RA   Williams A.R., Bates P.A., Smyth J.F., Gabra H.;
RT   "OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor
RT   function in epithelial ovarian cancer.";
RL   Nat. Genet. 34:337-343(2003).
CC   -!- FUNCTION: Binds opioids in the presence of acidic lipids; probably
CC       involved in cell contact.
CC   -!- INTERACTION:
CC       Q14982; P60410: KRTAP10-8; NbExp=3; IntAct=EBI-6447201, EBI-10171774;
CC       Q14982; Q701N4: KRTAP5-2; NbExp=3; IntAct=EBI-6447201, EBI-11958178;
CC       Q14982; Q8N1F7: NUP93; NbExp=3; IntAct=EBI-6447201, EBI-1042703;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor, GPI-
CC       anchor {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q14982-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14982-2; Sequence=VSP_043440;
CC       Name=3;
CC         IsoId=Q14982-3; Sequence=VSP_047730;
CC       Name=4;
CC         IsoId=Q14982-4; Sequence=VSP_054155;
CC   -!- DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer
CC       defines malignancies originating from ovarian tissue. Although many
CC       histologic types of ovarian tumors have been described, epithelial
CC       ovarian carcinoma is the most common form. Ovarian cancers are often
CC       asymptomatic and the recognized signs and symptoms, even of late-stage
CC       disease, are vague. Consequently, most patients are diagnosed with
CC       advanced disease. {ECO:0000269|PubMed:12819783}. Note=Disease
CC       susceptibility is associated with variants affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily. IgLON family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/OPCMLID44423ch11q25.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L34774; AAA36387.1; -; mRNA.
DR   EMBL; EU562296; ACB56656.1; -; mRNA.
DR   EMBL; EU562297; ACB56657.1; -; mRNA.
DR   EMBL; EU562299; ACB56659.1; -; mRNA.
DR   EMBL; AK299908; BAG61748.1; -; mRNA.
DR   EMBL; AK316491; BAH14862.1; -; mRNA.
DR   EMBL; BX537377; CAD97619.1; -; mRNA.
DR   EMBL; AP000843; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP000863; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP000903; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP003029; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP003784; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP003972; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP004606; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP004782; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP005122; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP005133; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP005638; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC074773; AAH74773.1; -; mRNA.
DR   EMBL; BC117254; AAI17255.1; -; mRNA.
DR   EMBL; BC126251; AAI26252.1; -; mRNA.
DR   EMBL; BC143946; AAI43947.1; -; mRNA.
DR   CCDS; CCDS31722.1; -. [Q14982-2]
DR   CCDS; CCDS81649.1; -. [Q14982-3]
DR   CCDS; CCDS8492.1; -. [Q14982-1]
DR   PIR; JC4025; JC4025.
DR   RefSeq; NP_001012393.1; NM_001012393.2. [Q14982-2]
DR   RefSeq; NP_001306032.1; NM_001319103.1. [Q14982-4]
DR   RefSeq; NP_001306033.1; NM_001319104.1.
DR   RefSeq; NP_001306034.1; NM_001319105.1. [Q14982-3]
DR   RefSeq; NP_001306035.1; NM_001319106.1.
DR   RefSeq; NP_002536.1; NM_002545.4. [Q14982-1]
DR   RefSeq; XP_011541158.1; XM_011542856.2. [Q14982-3]
DR   PDB; 5UV6; X-ray; 2.65 A; A/B=36-316.
DR   PDBsum; 5UV6; -.
DR   SMR; Q14982; -.
DR   BioGRID; 111026; 18.
DR   IntAct; Q14982; 14.
DR   STRING; 9606.ENSP00000330862; -.
DR   GlyGen; Q14982; 6 sites.
DR   iPTMnet; Q14982; -.
DR   PhosphoSitePlus; Q14982; -.
DR   BioMuta; OPCML; -.
DR   DMDM; 2497326; -.
DR   jPOST; Q14982; -.
DR   MassIVE; Q14982; -.
DR   MaxQB; Q14982; -.
DR   PaxDb; Q14982; -.
DR   PeptideAtlas; Q14982; -.
DR   PRIDE; Q14982; -.
DR   ProteomicsDB; 3410; -.
DR   ProteomicsDB; 60274; -. [Q14982-1]
DR   ProteomicsDB; 60275; -. [Q14982-2]
DR   ProteomicsDB; 7231; -.
DR   Antibodypedia; 53494; 211 antibodies.
DR   DNASU; 4978; -.
DR   Ensembl; ENST00000331898; ENSP00000330862; ENSG00000183715. [Q14982-1]
DR   Ensembl; ENST00000374778; ENSP00000363910; ENSG00000183715. [Q14982-3]
DR   Ensembl; ENST00000524381; ENSP00000434750; ENSG00000183715. [Q14982-2]
DR   Ensembl; ENST00000541867; ENSP00000445496; ENSG00000183715. [Q14982-4]
DR   Ensembl; ENST00000612177; ENSP00000482061; ENSG00000183715. [Q14982-1]
DR   GeneID; 4978; -.
DR   KEGG; hsa:4978; -.
DR   UCSC; uc001qgs.4; human. [Q14982-1]
DR   CTD; 4978; -.
DR   DisGeNET; 4978; -.
DR   GeneCards; OPCML; -.
DR   HGNC; HGNC:8143; OPCML.
DR   HPA; ENSG00000183715; Tissue enriched (brain).
DR   MalaCards; OPCML; -.
DR   MIM; 167000; phenotype.
DR   MIM; 600632; gene.
DR   neXtProt; NX_Q14982; -.
DR   OpenTargets; ENSG00000183715; -.
DR   PharmGKB; PA31930; -.
DR   VEuPathDB; HostDB:ENSG00000183715.13; -.
DR   eggNOG; KOG3510; Eukaryota.
DR   GeneTree; ENSGT00940000160304; -.
DR   HOGENOM; CLU_027228_2_2_1; -.
DR   InParanoid; Q14982; -.
DR   OMA; TVVWHRN; -.
DR   OrthoDB; 583722at2759; -.
DR   PhylomeDB; Q14982; -.
DR   TreeFam; TF325565; -.
DR   PathwayCommons; Q14982; -.
DR   Reactome; R-HSA-163125; Post-translational modification: synthesis of GPI-anchored proteins.
DR   BioGRID-ORCS; 4978; 2 hits in 985 CRISPR screens.
DR   ChiTaRS; OPCML; human.
DR   GeneWiki; OPCML; -.
DR   GenomeRNAi; 4978; -.
DR   Pharos; Q14982; Tbio.
DR   PRO; PR:Q14982; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q14982; protein.
DR   Bgee; ENSG00000183715; Expressed in Brodmann (1909) area 23 and 157 other tissues.
DR   ExpressionAtlas; Q14982; baseline and differential.
DR   Genevisible; Q14982; HS.
DR   GO; GO:0031225; C:anchored component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0008038; P:neuron recognition; TAS:ProtInc.
DR   Gene3D; 2.60.40.10; -; 3.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   Pfam; PF07679; I-set; 2.
DR   SMART; SM00409; IG; 3.
DR   SMART; SM00408; IGc2; 3.
DR   SUPFAM; SSF48726; SSF48726; 3.
DR   PROSITE; PS50835; IG_LIKE; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Cell membrane;
KW   Disease variant; Disulfide bond; Glycoprotein; GPI-anchor;
KW   Immunoglobulin domain; Lipoprotein; Membrane; Reference proteome; Repeat;
KW   Signal.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000250"
FT   CHAIN           28..322
FT                   /note="Opioid-binding protein/cell adhesion molecule"
FT                   /id="PRO_0000015118"
FT   PROPEP          323..345
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000015119"
FT   DOMAIN          39..126
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          136..219
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          223..310
FT                   /note="Ig-like C2-type 3"
FT   LIPID           322
FT                   /note="GPI-anchor amidated asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        44
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        70
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        140
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        285
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        293
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        306
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        57..115
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        157..202
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        244..296
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         1..41
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.2"
FT                   /id="VSP_047730"
FT   VAR_SEQ         1..27
FT                   /note="MGVCGYLFLPWKCLVVVSLRLLFLVPT -> MYHPAYWVVFSATTALLFIP
FT                   (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:17974005, ECO:0000303|Ref.2"
FT                   /id="VSP_043440"
FT   VAR_SEQ         312
FT                   /note="Y -> YEISPSSAVA (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_054155"
FT   VARIANT         95
FT                   /note="P -> R (in ovarian cancer; somatic mutation;
FT                   dbSNP:rs137852691)"
FT                   /evidence="ECO:0000269|PubMed:12819783"
FT                   /id="VAR_055421"
FT   STRAND          44..48
FT                   /evidence="ECO:0007744|PDB:5UV6"
FT   STRAND          53..58
FT                   /evidence="ECO:0007744|PDB:5UV6"
FT   STRAND          63..70
FT                   /evidence="ECO:0007744|PDB:5UV6"
FT   STRAND          73..77
FT                   /evidence="ECO:0007744|PDB:5UV6"
FT   STRAND          88..94
FT                   /evidence="ECO:0007744|PDB:5UV6"
FT   STRAND          97..102
FT                   /evidence="ECO:0007744|PDB:5UV6"
FT   HELIX           107..109
FT                   /evidence="ECO:0007744|PDB:5UV6"
FT   STRAND          111..121
FT                   /evidence="ECO:0007744|PDB:5UV6"
FT   STRAND          127..141
FT                   /evidence="ECO:0007744|PDB:5UV6"
FT   STRAND          145..148
FT                   /evidence="ECO:0007744|PDB:5UV6"
FT   STRAND          153..163
FT                   /evidence="ECO:0007744|PDB:5UV6"
FT   STRAND          166..171
FT                   /evidence="ECO:0007744|PDB:5UV6"
FT   STRAND          180..191
FT                   /evidence="ECO:0007744|PDB:5UV6"
FT   HELIX           194..196
FT                   /evidence="ECO:0007744|PDB:5UV6"
FT   STRAND          198..205
FT                   /evidence="ECO:0007744|PDB:5UV6"
FT   STRAND          207..209
FT                   /evidence="ECO:0007744|PDB:5UV6"
FT   STRAND          212..228
FT                   /evidence="ECO:0007744|PDB:5UV6"
FT   STRAND          240..250
FT                   /evidence="ECO:0007744|PDB:5UV6"
FT   STRAND          253..258
FT                   /evidence="ECO:0007744|PDB:5UV6"
FT   STRAND          270..274
FT                   /evidence="ECO:0007744|PDB:5UV6"
FT   STRAND          276..285
FT                   /evidence="ECO:0007744|PDB:5UV6"
FT   TURN            288..290
FT                   /evidence="ECO:0007744|PDB:5UV6"
FT   STRAND          292..300
FT                   /evidence="ECO:0007744|PDB:5UV6"
FT   STRAND          303..312
FT                   /evidence="ECO:0007744|PDB:5UV6"
SQ   SEQUENCE   345 AA;  38008 MW;  E7AD17BEA1AA3FF4 CRC64;
     MGVCGYLFLP WKCLVVVSLR LLFLVPTGVP VRSGDATFPK AMDNVTVRQG ESATLRCTID
     DRVTRVAWLN RSTILYAGND KWSIDPRVII LVNTPTQYSI MIQNVDVYDE GPYTCSVQTD
     NHPKTSRVHL IVQVPPQIMN ISSDITVNEG SSVTLLCLAI GRPEPTVTWR HLSVKEGQGF
     VSEDEYLEIS DIKRDQSGEY ECSALNDVAA PDVRKVKITV NYPPYISKAK NTGVSVGQKG
     ILSCEASAVP MAEFQWFKEE TRLATGLDGM RIENKGRMST LTFFNVSEKD YGNYTCVATN
     KLGNTNASIT LYGPGAVIDG VNSASRALAC LWLSGTLLAH FFIKF
//
